Business

Novartis Deepens Commitment to India with Launch ofPluvicto®, the Country’s First Regulatory Authority Approved Radioligand Therapy for Advanced Prostate Cancer

0 comments

June 2026 • Prostate cancer is a growing health challenge in India, withover 250,000 cases1 annually and more than half detected atadvanced stages, underscoring the urgent need for earlierdiagnosis and improved access to advanced treatment options. • Radioligand therapy introduces a more targeted treatment approach with the potential to delay disease progression, support overall [more…]